FDA Drug Application (022473) for REVATIO by PFIZER

Back to FDA Applications sponsored by PFIZER

Application Number022473
Product Number001
FormSOLUTION;INTRAVENOUS
DosageEQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameREVATIO
Active IngredientSILDENAFIL CITRATE

Active IngredientCount
List of drugs with Active Ingredient SILDENAFIL CITRATE3


Back to FDA Applications sponsored by PFIZER